PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Département de Médecine sociale et préventive, Université Laval, CRIUCPQ, 2725, Chemin Sainte-Foy, Québec, QC, G1G 4G5, Canada. philippe.dewals@criucpq.ulaval.ca.\', \'Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Québec, Canada. philippe.dewals@criucpq.ulaval.ca.\', \'Centre de recherche de l\'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada. philippe.dewals@criucpq.ulaval.ca.\', \'Montreal Chest Institute and Respiratory Epidemiology Unit, McGill University, Montreal, Quebec, Canada.\', \'Meakins-Christie Laboratories, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.\', \'Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.\', \'McGill International TB Centre, McGill University Health Centre, Montreal, QC, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.17269/s41997-020-00439-7
?:hasPublicationType
?:journal
  • Canadian journal of public health = Revue canadienne de sante publique
is ?:pmid of
?:pmid
?:pmid
  • 33211246
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all